Different time-dependent changes of risk for evolution in chronic lymphocytic leukemia with mutated or unmutated antigen B cell receptors

Warning

This publication doesn't include Faculty of Medicine. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Authors	MOYSIADIS T. BALIAKAS P. ROSSI D. CATHERWOOD M. STREFFORD J.C. DELGADO J. ANAGNOSTOPOULOS A. BELESSI C. STAVROYIANNI N. POSPÍŠILOVÁ Šárka OSCIER D. GAIDANO G. CAMPO E. ROSENQUIST R. GHIA P. STAMATOPOULOS K.
Year of publication	2019
Type	Article in Periodical
Magazine / Source	Leukemia
MU Faculty or unit	Central European Institute of Technology
Citation
Web	https://www.nature.com/articles/s41375-018-0322-7
Doi	http://dx.doi.org/10.1038/s41375-018-0322-7
Keywords	SURVIVAL
Attached files	Figures_and_Tables_Hazard_paper__supplemental__181024_final.docx Figures_and_Tables_Hazard_paper__supplemental__181024_final.pdf Hazard_paper_20180807_ref.docx Hazard_paper_revised_ref_181024_final.docx
Description	Chronic lymphocytic leukemia (CLL) displays remarkable clinical heterogeneity, likely attributed to the underlying biological diversity. This claim is supported by the fact that certain immunogenetic and/or genomic features identify subgroups of CLL patients with distinct prognosis and outcome.
Related projects:	MEDGENET - Medical genomics and epigenomics network CEITEC 2020